Alnylam Pharmaceuticals Stock Predictions

AI Is Changing Marketing Forever-Invest Before the Boom

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering. Please read the offering circular and related risks at invest.radintel.ai.

Sell

ALNY
Alnylam Pharmaceuticals

Last Price:

$241.77

Seasonality Move:

0.38%

7 Day Trial

ALL ACCESS PASS

$ 7

Invest in the Future of AI-Driven Marketing

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering. Please read the offering circular and related risks at invest.radintel.ai.

Alnylam Pharmaceuticals Stock Forecast

Over the next 52 weeks, Alnylam Pharmaceuticals has on average historically risen by 35.3% based on the past 20 years of stock performance.
Alnylam Pharmaceuticals has risen higher in 14 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 70%
Is Alnylam Pharmaceuticals Stock Undervalued?

The current Alnylam Pharmaceuticals [ALNY] share price is $241.76. The Score for ALNY is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
ALNY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Alnylam Pharmaceuticals Stock Go Up Next Year?

Over the next 52 weeks, Alnylam Pharmaceuticals has on average historically risen by 35.3% based on the past 20 years of stock performance.

Alnylam Pharmaceuticals Stock Rating

Sell

Alnylam Pharmaceuticals (ALNY) is a Sell

Is Alnylam Pharmaceuticals overpriced?

Alnylam Pharmaceuticals has risen higher in 14 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 70%

Alnylam Pharmaceuticals Stock Price History

Is ALNY stock going to rise?

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALNY is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

alnylam.com

52-Week Data

52-Week High:

304.39

52-Week Low:

141.98

Prediction Charts

Market Cap:

31.3B

Price in USD:

241.76

Volume:

478.8K

Beta:

1.20

Technical Analysis

SMA50:

254.18

SMA100:

257.94

SMA200:

248.08

52-Wk Change:

62.77%

Stock Predictions

Is Alnylam Pharmaceuticals stock public?

Yes, Alnylam Pharmaceuticals is a publicly traded company.
What is the Alnylam Pharmaceuticals stock quote today?

The Alnylam Pharmaceuticals stock price is 241.76 USD today.
How to buy Alnylam Pharmaceuticals stock online?

You can buy Alnylam Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Feb-21	253.70	250.59	253.70	246.85
Feb-25	251.50	245.04	251.56	238.46
Feb-26	246.72	243.86	251.60	243.45
Feb-27	244.73	237.10	246.38	236.55
Feb-28	236.50	246.75	249.34	236.50
Mar-3	246.18	243.78	250.00	241.91
Mar-4	241.09	242.93	244.67	238.42
Mar-5	243.02	249.23	249.82	241.55
Mar-6	244.57	248.13	252.84	244.57
Mar-7	247.14	244.52	251.12	240.98
Mar-11	230.85	238.74	243.45	230.79
Mar-12	241.57	242.43	246.37	240.39
Mar-13	240.96	241.75	245.14	239.02
Mar-14	241.51	241.76	244.04	239.53

Alnylam Pharmaceuticals Earnings

Alnylam Pharmaceuticals Earnings Report: Per Share Alnylam Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.

Alnylam Pharmaceuticals Forecast Revenue Growth

Alnylam Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for Alnylam Pharmaceuticals and historical quarterly revenue growth:

Analysts estimate an earnings increase this quarter of $0.75 per share, an increase next quarter of $1.48 per share, an increase this year of $0.76 per share, and an increase next year of $2.81 per share.

* Alnylam Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.